SKI Market

A+| A| A-|

Indian Indices

Sensex

77,988.68 -122.56
( -0.16%)

Global Indices

Nasdaq

48,485.12 -71.88
(-0.15%)

Dow Jones

7,044.29 55.91
(0.80%)

Hang Seng

59,591.25 1,457.01
(2.51%)

Nikkei 225

10,588.49 28.91
(0.27%)

Forex

USD-INR

93.24 -0.60
(-0.63%)

EUR-INR

109.88 0.00
(0.00%)

GBP-INR

126.32 0.15
(0.12%)

JPY-INR

0.59 0.00
(-0.22%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Hester Biosciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524669

INE782E01017

409.0776861

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HESTERBIO

34.68

1226.01

EPS(TTM)

Face Value()

Div & Yield %

41.56

0.49

Back

Davangere Sugar Company standalone net profit declines 61.30% in the December 2025 quarter

Feb 11,2026

Net profit of Davangere Sugar Company declined 61.30% to Rs 2.62 crore in the quarter ended December 2025 as against Rs 6.77 crore during the previous quarter ended December 2024. Sales rose 13.00% to Rs 82.69 crore in the quarter ended December 2025 as against Rs 73.18 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	82.69	73.18	13
OPM %	16.21	24.90	-
PBDT	7.69	10.47	-27
PBT	4.52	7.47	-39
NP	2.62	6.77	-61

77,988.68 -122.56 ( -0.16%)

48,485.12 -71.88 (-0.15%)

7,044.29 55.91 (0.80%)

59,591.25 1,457.01 (2.51%)

10,588.49 28.91 (0.27%)

93.24 -0.60 (-0.63%)

109.88 0.00 (0.00%)

126.32 0.15 (0.12%)

0.59 0.00 (-0.22%)